[go: up one dir, main page]

PE20160940A1 - RECOMBINANT NEWCASTLE EXPRESSING THE PROTEINS OF THE AVIAN BRONCHITIS VIRUS AND ITS APPLICATIONS - Google Patents

RECOMBINANT NEWCASTLE EXPRESSING THE PROTEINS OF THE AVIAN BRONCHITIS VIRUS AND ITS APPLICATIONS

Info

Publication number
PE20160940A1
PE20160940A1 PE2014001179A PE2014001179A PE20160940A1 PE 20160940 A1 PE20160940 A1 PE 20160940A1 PE 2014001179 A PE2014001179 A PE 2014001179A PE 2014001179 A PE2014001179 A PE 2014001179A PE 20160940 A1 PE20160940 A1 PE 20160940A1
Authority
PE
Peru
Prior art keywords
expressing
proteins
applications
bronchitis virus
newcastle disease
Prior art date
Application number
PE2014001179A
Other languages
Spanish (es)
Inventor
Mendoza Ana Luz Chumbe
Lara Ray William Izquierdo
Diaz Manolo Clemente Fernandez
Original Assignee
Farvet S A C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farvet S A C filed Critical Farvet S A C
Priority to PE2014001179A priority Critical patent/PE20160940A1/en
Publication of PE20160940A1 publication Critical patent/PE20160940A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invencion se relaciona con una composicion inmunogenica o vacuna, y en un aspecto mas particular, se refiere a un constructo viral que utiliza como esqueleto al virus de la enfermedad de Newcastle, el cual ha sido recombinado molecularmente para incorporar un gen foraneo de IBV. En particular, se relaciona con un vector viral recombinante derivado del virus de la enfermedad de Newcastle (NDV) que comprende un gen proveniente del virus de bronquitis infecciosa aviar (IBV), y al producto correspondiente a una formulacion inmunogenica o vacuna formulada para inmunizar contra la enfermedad de Newcastle y la bronquitis infecciosa aviarThe invention relates to an immunogenic composition or vaccine, and in a more particular aspect, it refers to a viral construct that uses the Newcastle disease virus as a backbone, which has been molecularly recombined to incorporate a foreign IBV gene. In particular, it is related to a recombinant viral vector derived from Newcastle disease virus (NDV) that comprises a gene from avian infectious bronchitis virus (IBV), and to the product corresponding to an immunogenic formulation or vaccine formulated to immunize against Newcastle disease and avian infectious bronchitis

PE2014001179A 2014-07-25 2014-07-25 RECOMBINANT NEWCASTLE EXPRESSING THE PROTEINS OF THE AVIAN BRONCHITIS VIRUS AND ITS APPLICATIONS PE20160940A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PE2014001179A PE20160940A1 (en) 2014-07-25 2014-07-25 RECOMBINANT NEWCASTLE EXPRESSING THE PROTEINS OF THE AVIAN BRONCHITIS VIRUS AND ITS APPLICATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PE2014001179A PE20160940A1 (en) 2014-07-25 2014-07-25 RECOMBINANT NEWCASTLE EXPRESSING THE PROTEINS OF THE AVIAN BRONCHITIS VIRUS AND ITS APPLICATIONS

Publications (1)

Publication Number Publication Date
PE20160940A1 true PE20160940A1 (en) 2016-09-25

Family

ID=58605941

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014001179A PE20160940A1 (en) 2014-07-25 2014-07-25 RECOMBINANT NEWCASTLE EXPRESSING THE PROTEINS OF THE AVIAN BRONCHITIS VIRUS AND ITS APPLICATIONS

Country Status (1)

Country Link
PE (1) PE20160940A1 (en)

Similar Documents

Publication Publication Date Title
MX2022006603A (en) Broad spectrum influenza virus vaccine.
CL2018001056A1 (en) Herpes simplex virus vaccine
CL2017000780A1 (en) Compositions and methods to silence the expression of the hepatitis b gene virus
EA201591287A1 (en) VACCINES CONTAINING STABILIZED TRIMMERS OF THE HUMAN IMMUNODEFICIENCY VIRUS VIRUS, AND METHODS OF THEIR USE
EA201891415A8 (en) HUMAN IMMUNODEFICIENCY VIRUS ANTIGENS, VECTORS, COMPOSITIONS AND WAYS OF THEIR APPLICATION
BR112017001310A2 (en) coronavirus
EP4043031A3 (en) Zika viral antigen constructs
PH12019500854A1 (en) Recombinant vectors expressing antigens of avian influenza virus and uses thereof
WO2015052543A3 (en) Malaria vaccination
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MX2021010060A (en) Production of viruses in avian eggs.
AR080313A1 (en) COMPOSITIONS OF RECOMBINANT CANINE MACHINE VIRUS (CDV) AND ITS USES
EP3939604A3 (en) Influenza hemagglutinin protein vaccines
CL2018001946A1 (en) Attenuated viruses of infectious bronchitis.
MX2017016896A (en) Inactivated canine influenza vaccines and methods of making and uses thereof.
MX363149B (en) Influenza nucleoprotein vaccines.
MX2019005102A (en) Synthetic chimeric poxviruses.
CL2019000705A1 (en) New promoters
MX373809B (en) RECOMBINANT SWINEPOX VIRUS AND VACCINES.
MX2018014955A (en) Equine influenza virus live-attenuated vaccines.
WO2014140166A3 (en) Vaccine
MX2019007924A (en) Influenza vaccines.
CR20140432A (en) VIRUS OF THE MODIFIED MAREK'S DISEASE AND VACCINES PREPARED WITH THE
PE20160940A1 (en) RECOMBINANT NEWCASTLE EXPRESSING THE PROTEINS OF THE AVIAN BRONCHITIS VIRUS AND ITS APPLICATIONS
EA201892385A1 (en) MODIFICATION OF CONSTRUCTED POLYPEPTIDES OF THE HYMAGGLUTININ OF THE FLU VIRUS

Legal Events

Date Code Title Description
FG Grant, registration